LINC02905 as A Cancer Treatment Target (G606553)

Target Name: LINC02905

NCBI ID: G606553

LINC02905

LINC02905 as A Cancer Treatment Target

LINC02905 (G4DM) is a protein that is expressed in various tissues of the body, including the brain. It is a key regulator of the cell cycle, and is involved in the development and progression of many diseases, including cancer.

Recent studies have identified LINC02905 as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. LINC02905 has been shown to play a role in the regulation of the cell cycle, and has been linked to the development of cancer.

One of the key mechanisms by which LINC02905 is involved in cancer development is its role in the regulation of the microtubules of the cell. Microtubules are important structures that help keep cells in motion and ensure the proper delivery of materials to different parts of the cell.

Research has shown that LINC02905 plays a key role in the regulation of microtubule dynamics and stability. This is important because changes in microtubule dynamics and stability can contribute to the development and progression of cancer.

Another mechanism by which LINC02905 may be involved in cancer development is its role in the regulation of cell adhesion. Adhesion is the process by which cells stick together and form tissues.

Research has shown that LINC02905 plays a key role in the regulation of cell adhesion. This is important because changes in cell adhesion can contribute to the development and progression of cancer.

In addition to its role in the regulation of microtubules and cell adhesion, LINC02905 has also been shown to play a key role in the development and progression of cancer. For example, studies have shown that LINC02905 is overexpressed in many types of cancer, and that its levels are often higher in cancer cells than in normal cells.

Overall, LINC02905 is a protein that is involved in the regulation of many important cellular processes that are involved in the development and progression of cancer. As such, it is a potential drug target (or biomarker) for the treatment of cancer. Further research is needed to fully understand the role of LINC02905 in cancer development and to develop effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 2905

The "LINC02905 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02905 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets